Pipeline
| Drug candidate | Indication | Discovery | Pre-clinical | Phase I/II | Phase IIb/III |
|---|---|---|---|---|---|
| SL-28 | Head and NeckOral cavityThyroid cancer | ||||
| SL-28 | ThoracicSmall-cell lung cancerNon-small cell lung cancerMesotheliomaEsophageal cancer | ||||
| SL-28 | GastrointestinalGastric cancerLiver cancerColorectal cancerPancreatic cancer | ||||
| SL-28 | GenitourinaryBladder cancerRenal cell carcinomaProstate cancer | ||||
| SL-28 | GynecologicOvarian cancerEndometrial cancer | ||||
| SL-28 | Breast and SkinBreast cancerMelanoma | ||||